[1]
Bianchera, A.; Alomari, E.; Bruno, S. Augmentation therapy with alpha 1-antitrypsin: present and future of production, formulation and delivery. Curr. Med. Chem., 2022, 29(3), 385-410.
[2]
Cioni, P.; Gabellieri, E.; Campanini, B.; Bettati, S.; Raboni, S. Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications. Curr. Med. Chem., 2022, 29(3), 411-452.
[3]
Garg, H.; Tatiossian, K.; Peppel, K.; Kato, G.J.; Herzog, E. Gene therapy as the new frontier for Sickle Cell Disease. Curr. Med. Chem., 2022, 29(3), 453-466.
[4]
Karnaukhova, E. C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development. Curr. Med. Chem., 2022, 29(3), 467-488.
[5]
Marchetti, M.; Faggiano, S.; Mozzarelli, A. Enzyme Replacement Therapy for Genetic Disorders Associated with Enzyme Deficiency. Curr. Med. Chem., 2022, 29(3), 489-525.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
19
2